Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2006-02-15 4 OE $10.50 $52,500 D/D 5,000 13,000 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2006-04-07 4 A $0.00 $0 D/D 4,272 12,272 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2006-11-13 4 OE $10.50 $84,000 D/D 8,000 20,272 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2006-11-13 4 AS $42.76 $342,175 D/D (8,000) 12,272 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-01-15 4 A $0.00 $0 D/D 4,000 16,272 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-03-12 4 AS $37.15 $28,160 D/D (758) 15,514 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-04-03 4 AS $43.52 $413,673 D/D (9,500) 15,514 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-04-03 4 OE $10.50 $99,750 D/D 9,500 25,014 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-06-01 4 AS $48.50 $1,212,500 D/D (25,000) 25,014 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-06-01 4 OE $9.00 $229,375 D/D 25,000 50,014 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-07-25 4 AS $56.50 $1,414,306 D/D (25,000) 20,512 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-07-25 4 OE $9.00 $242,425 D/D 25,000 45,512 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-09-10 4 AS $65.31 $13,650 D/D (209) 20,303 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-11-05 4 AS $75.03 $2,625,900 D/D (34,998) 13,772 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-11-05 4 OE $21.00 $702,765 D/D 33,465 48,770 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-01-09 4 A $0.00 $0 D/D 3,000 16,772 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-01-10 4 S $69.02 $49,142 D/D (712) 16,060 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-03-10 4 S $56.05 $8,912 D/D (159) 15,901 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research & Devel   •       –      –    2008-05-19 4 AS $69.72 $2,501,336 D/D (35,827) 15,901 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research & Devel   •       –      –    2008-05-19 4 OE $10.74 $627,956 D/D 35,827 51,728 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research & Devel   •       –      –    2008-07-10 4 S $75.75 $12,044 D/D (159) 15,742 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-09-11 4 S $40.20 $12,824 D/D (319) 31,165 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-10-29 4 GD $0.00 $0 D/D 3,852 31,165 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-10-30 4 GD $0.00 $0 D/D 3,852 27,313 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-01-12 4 S $34.48 $12,930 D/D (375) 26,938 0 -
  148  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us